CALL US : +1 717-208-8666
Your are here : Home / Webinar / Life Sciences and Healthcare (Live)
Monitoring and Investigating Drug Diversion
Jay Anstine

Jay Anstine Keynote Speaker at Compliance key Inc. He is the President of Bluebird Healthlaw Partners, LLC. As a healthcare lawyer specializing in regulatory compliance, Mr. Anstine consults to physicians, senior management, and boards of directors on compliance programs and regulatory issues impacting operations.

Mr. An

View More  
This webinar will walk attendees through monitoring against drug diversion and investigating alleged diversions. More specifically, it will discuss the warning signs of diversion, common methods used to carry out diversion, potential organizational vulnerabilities, investigating a diversion case from beginning to end, and offer tips for safeguarding against diversion. To help highlight certain discussion points, Mr. Anstine will additionally cover selected real life cases of drug diversion that have occurred inside healthcare organizations by workforce members.
Why should you attend this webinar?
As prescription drug abuse has significantly increased over recent years in the United States, so too have reported cases of drug diversions by healthcare workers (clinical or administrative). Diversions can range from workforce members pocketing pills to injecting oneself and reusing supplies that later infect patients. As a consequence, how an organization monitors and investigates drug diversion will vary as well as the organization's public exposure, which also must be managed. This webinar is therefore designed help educate attendees on drug diversion issues and how to respond to suspected diversions.
Areas Covered in the Session:
  • What is drug diversion?
  • Trends in the rise of diversion cases.
  • Signs of potential diversion.
  • How to investigate suspected drug diversion.
  • Reporting obligations to government agencies.
  • Recent notable drug diversion cases.
  • Questions and answers
Who can Benefit:
The target audience for this presentation will be new-to-the-profession compliance officers or existing staff that have taken on a compliance officer function within their organization and have responsibility for investigating diversion of controlled substances in the organization.
Product Id :  LSHCJA011
Training Options                        Duration: 90 mins
06/27/2017  10:00 AM PST | 01:00 PM EST
Single Attendee:   [Only for one participant]
Price: $165 (Live) Price: $270 (Live + Recorded)
Multiple Attendee:   [For a group of 2 to 5 participants]
Price: $335 (Live) Price: $440 (Live + Recorded)
Corporate Attendee:   [For a group of 6 - 10 Participants]
Price: $670 (Live) Price: $775 (Live + Recorded)
Recorded   [Six month unlimited access]
Price: $193
     Refund Policy
Upcoming Webinar of Jay Anstine
Clear, Complete, and Concise: Strategies for Writing an Investigation Report
Live 07/18/2017  Time: 10.00 AM PST | 01.00 PM EST
Tis the Season: Navigating the Compliance Challenges with Holiday Gifts
Live 11/15/2017  Time: 12.30 PM PST | 03.30 PM EST
More Webinars  
Past Webinar of Jay Anstine
Compliance Challenges with Legalized Marijuana
Live01/17/2017  Time: 10:00 AM PST | 01:00 PM EST
Your First 100 Days as a Compliance Officer: Strategies to Prioritize Your Workload.
Live01/27/2017  Time: 10:00 AM PST | 01:00 PM EST
More Webinars  
Upcoming Webinar :Life Sciences and Healthcare
How To Bill Medicare for Durable Medical Equipment and Stay Legal Compliant
Live 06/29/2017  Time: 10:00 AM PST | 01:00 PM EST
Employee Wellness Plans
Live 06/29/2017  Time: 12:30 PM PST | 03:30 PM EST
More Webinars  
Past Webinar : Life Sciences and Healthcare
Hazard Analysis following ISO 14971
Live 01/13/2017  Time: 10:00 PM PST | 01:00 PM EST
Creation of DHFs, DMRs, and DHRs utilizing the principles of Lean Documents and Lean Configuration
Live 01/13/2017  Time: 10:00 AM PST | 01:00 PM EST
More Webinars  

Customer Review




Twitter @ ComplianceKey


News Letter



Like us on Facebook

PayPal Acceptance Mark
Back to Top